Provided by Tiger Trade Technology Pte. Ltd.

Takeda Pharmaceutical Co Ltd

18.60
+0.34001.86%
Pre-market: 18.900.3045+1.64%04:01 EDT
Volume:2.36M
Turnover:43.92M
Market Cap:59.20B
PE:-55.03
High:18.70
Open:18.56
Low:18.54
Close:18.26
52wk High:18.90
52wk Low:12.99
Shares:3.18B
Float Shares:3.09B
Volume Ratio:1.17
T/O Rate:0.08%
Dividend:0.65
Dividend Rate:3.47%
EPS(TTM):-0.3380
EPS(LYR):-0.3042
ROE:-2.26%
ROA:2.69%
PB:1.21
PE(LYR):-61.14

Loading ...

NYSE Order Imbalance 114898.0 Shares on Sell Side

THOMSON REUTERS
·
Jul 31

Analysts Have Conflicting Sentiments on These Healthcare Companies: Takeda Pharmaceutical Company (TAK), Align Tech (ALGN) and Conmed (CNMD)

TIPRANKS
·
Jul 31

Takeda Pharmaceutical Fiscal Q1 Core Earnings, Revenue Rise

MT Newswires Live
·
Jul 30

Takeda Pharmaceutical Q1 Adj. EPS $0.48 Beats $0.39 Estimate, Sales $7.655B Beat $7.060B Estimate

Benzinga Earnings
·
Jul 30

Press Release: Takeda Announces Fy2026 First Quarter Results, Near-Term Launch Preparations and Pipeline Progress on Track

Dow Jones
·
Jul 30

Takeda’s Pediatric GERD Trial Update: What Dexlansoprazole Data Could Mean for TAK Investors

TIPRANKS
·
Jul 30

Takeda Pharmaceutical Co Ltd Expected to Post Earnings of Jpy140.99 a Share - Earnings Preview

Reuters
·
Jul 28

Takeda Expected to Post Lower First-Quarter Net Profit

Dow Jones
·
Jul 28

Takeda’s Elritercept Trial Targets Anemia in Myelofibrosis, Raising Long-Term Upside for TAK

TIPRANKS
·
Jul 25

Asian Equities Traded in the US as American Depositary Receipts Decline in Friday Trading

MT Newswires Live
·
Jul 24

Earning Preview: Takeda Pharmaceutical Co Ltd Q1 revenue is expected to decrease by 1.08%, and institutional views are bullish

Earnings Agent
·
Jul 24

Immigration: Foreign Lawbreakers May Face Indonesian Prison

Tempo
·
Jul 23

Takeda Pharmaceutical Reports Positive Phase 3 Data for Zasocitinib in Moderate-to-Severe Plaque Psoriasis

MT Newswires Live
·
Jul 17

Takeda’s TAK-226 Anemia Trial Offers New Optionality in Hematology

TIPRANKS
·
Jul 17

Takeda Extends TAK-360 Sleep Trial, Signaling Long-Term Ambitions in Narcolepsy

TIPRANKS
·
Jul 16

Takeda, Indonesian Government Launch Program to Build National Plasma Ecosystem

MT Newswires Live
·
Jul 13

Takeda, the Indoensian Government announce collaboration

TIPRANKS
·
Jul 13

Insilico Medicine Announces Strategic Collaboration with Takeda for AI-Driven Drug Discovery

Stock News
·
Jul 02

Takeda, Insilico Strike AI Drug-discovery Deal Worth up to $600.0 Million

Dow Jones
·
Jul 02

Alkermes Faces Risk on Orexin-Related Value From Upcoming Updates, BofA Says

MT Newswires Live
·
Jun 29